tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Appili Therapeutics Secures Shareholder Approval for Strategic Initiatives
Company AnnouncementsAppili Therapeutics Secures Shareholder Approval for Strategic Initiatives
7d ago
Appili Therapeutics to Showcase Tularemia Vaccine at NATO Conference
PremiumCompany Announcements
Appili Therapeutics to Showcase Tularemia Vaccine at NATO Conference
22d ago
Appili Therapeutics to present progress on Tularemia vaccine
PremiumThe Fly
Appili Therapeutics to present progress on Tularemia vaccine
22d ago
Appili Therapeutics Strengthens Biodefense Partnerships and Advances Drug Development
PremiumCompany Announcements
Appili Therapeutics Strengthens Biodefense Partnerships and Advances Drug Development
2M ago
Appili Therapeutics, colleagues publish manuscript on ATI-1701 efficacy
PremiumThe Fly
Appili Therapeutics, colleagues publish manuscript on ATI-1701 efficacy
2M ago
Appili Therapeutics Demonstrates Efficacy of Tularemia Vaccine Candidate
PremiumCompany AnnouncementsAppili Therapeutics Demonstrates Efficacy of Tularemia Vaccine Candidate
2M ago
Appili Therapeutics Advances Infectious Disease Solutions with LIKMEZ Re-launch and Vaccine Developments
Premium
Company Announcements
Appili Therapeutics Advances Infectious Disease Solutions with LIKMEZ Re-launch and Vaccine Developments
3M ago
Appili Therapeutics Ends Agreement with Aditxt, Secures Loan Extensions
Premium
Company Announcements
Appili Therapeutics Ends Agreement with Aditxt, Secures Loan Extensions
4M ago
Appili Therapeutics Faces Termination of Agreement with Aditxt
PremiumCompany Announcements
Appili Therapeutics Faces Termination of Agreement with Aditxt
4M ago
Aditxt announces termination of arrangement agreement with Appili Therapeutics
PremiumThe Fly
Aditxt announces termination of arrangement agreement with Appili Therapeutics
4M ago
ADTX
Appili Therapeutics Advances Tularemia Vaccine Research
PremiumCompany Announcements
Appili Therapeutics Advances Tularemia Vaccine Research
5M ago
Appili Therapeutics publishes manuscript on emergency response to tularemia
PremiumThe Fly
Appili Therapeutics publishes manuscript on emergency response to tularemia
5M ago
Appili Therapeutics Secures New Patents for LIKMEZ, Strengthening Market Position
PremiumCompany AnnouncementsAppili Therapeutics Secures New Patents for LIKMEZ, Strengthening Market Position
5M ago
Appili Therapeutics granted new patents for LIKMEZ
Premium
The Fly
Appili Therapeutics granted new patents for LIKMEZ
5M ago
Appili Therapeutics CEO to Discuss Strategic Growth and Funding Initiatives
Premium
Company Announcements
Appili Therapeutics CEO to Discuss Strategic Growth and Funding Initiatives
6M ago
Appili Therapeutics CEO to join Aditxt CEO for weekly update on April 4
PremiumThe Fly
Appili Therapeutics CEO to join Aditxt CEO for weekly update on April 4
6M ago
ADTX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
PLX
SLS
Appili Therapeutics Seeks $117.5 Million in Federal Funding for Infectious Disease Treatments
PremiumCompany Announcements
Appili Therapeutics Seeks $117.5 Million in Federal Funding for Infectious Disease Treatments
7M ago
Appili Therapeutics announces submission of government funding proposals
PremiumThe Fly
Appili Therapeutics announces submission of government funding proposals
7M ago
Appili Therapeutics expects Aditxt transaction to close in Q1
PremiumThe FlyAppili Therapeutics expects Aditxt transaction to close in Q1
7M ago
ADTX
Appili Therapeutics Advances Pipeline with Strong Shareholder and Government Support
Premium
Company Announcements
Appili Therapeutics Advances Pipeline with Strong Shareholder and Government Support
8M ago
Appili Therapeutics Moves Forward with Aditxt Acquisition
Premium
Company Announcements
Appili Therapeutics Moves Forward with Aditxt Acquisition
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >